BIO-Europe Spring^® 2012 Press Releases

November 21, 2011Global biotechnology industry to gather in Amsterdam for BIO-Europe Spring^® 2012 The global biotechnology industry's top dealmakers and leaders will gather for one of the "must attend" partnering events on the calendar, the sixth annual BIO-Europe Spring^® partnering conference in Amsterdam, March 19–21, 2012 at the Amsterdam RAI Convention Center. This year's edition is enhanced by being held in The Netherlands, a world-class research community ready to...more ►

16 January 2012 Biotech funding 2012: Innovation is not enough Venture capital is the most expensive form of capital, so companies are advised to be creative in sourcing other types of funding. With the current capital headwinds, creative alternatives may be the only options companies have. more ►

13 January 2012 The number two killer globally, infectious disease is a great place to invest Infectious diseases are the number two killer globally, just behind cardiovascular disease. Aside from the scientific challenges, biotech companies conducting infectious disease work are moving from seemingly random approaches to iterative optimizations that deliver candidates on schedule, cost-effectively, said expert panelists at Biotech Showcase™ 2012. more ►

4 January 2012 Harry Glorikian: Opportunities in this market are abundant, but not obvious For many years Harry Glorikian, Managing Director, Scientia Advisors has been helping companies navigate the dynamic, yet increasingly turbulent, life science market. Over the holidays we had the chance to meet with Glorikian to get a peek at what’s in store for several sectors in the healthcare industry in 2012 and beyond. more ►

4 January 2012 Anton Gueth: Troublesome financing environment to hit early stage companies hard in 2012 The excitement of the industry insiders is unfortunately not matched by those funding and regulating it. The challenges facing the industry are increasing every day. more ►

4 January 2012 Video: Recognizing and avoiding mistakes that can cost you the deal Valuable lessons are learned when experienced business development executives draw from their dealmaking experience and dive into some of the common and not so common pitfalls in partnering. more ►